(NASDAQ:ASO) stands against the other best NASDAQ stocks ... The year-end targets for the S&P 500 might be too optimistic. If ...
In a recent study, Bunting et al. use an antisense oligonucleotide (ASO) to silence MSH3, a DNA mismatch repair protein that drives CAG repeat expansion. In patient-derived cells and mouse models ...